The first monoclonal antibody for cancer

    The FDA just approved the first monoclonal antibody for cancer...Rituxan (rituximab) from Genentech.

    It's for certain cases of non-Hodgkin's lymphoma

    Rituxan binds to an antigen on mature B-cells...allowing the immune system to recognize and eliminate them.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote